Li Li, director of the State Drug Administration, said in an interview that he will insist on improving quality and efficiency and speeding up the launch of innovative pharmaceutical devices. Implement the national drug standards improvement plan, strengthen research on cutting-edge technologies such as cell therapy products, radiopharmaceuticals, artificial intelligence products, etc., improve technical principles and product standards for relevant product registration and application, and give full play to the leading role of standards in R&D and innovation. Optimize the registration inspection process, reduce the amount of registered inspection samples, reduce the inspection cycle, reduce enterprise costs, and shorten the pharmaceutical product marketing cycle. Accelerate the improvement of intellectual property protection related systems such as drug test data protection, speed up the transformation and application of original research results on pharmaceuticals and medical devices, and enhance the core competitiveness of China's pharmaceutical industry. Raise the level of development of intelligent supervision, promote “artificial intelligence+drug supervision”, explore the implementation of artificial intelligence-assisted reviews, and promote technological empowerment.

Li Li, director of the State Drug Administration, said in an interview that he will insist on improving quality and efficiency and speeding up the launch of innovative pharmaceutical devices. Implement the national drug standards improvement plan, strengthen research on cutting-edge technologies such as cell therapy products, radiopharmaceuticals, artificial intelligence products, etc., improve technical principles and product standards for relevant product registration and application, and give full play to the leading role of standards in R&D and innovation. Optimize the registration inspection process, reduce the amount of registered inspection samples, reduce the inspection cycle, reduce enterprise costs, and shorten the pharmaceutical product marketing cycle. Accelerate the improvement of intellectual property protection related systems such as drug test data protection, speed up the transformation and application of original research results on pharmaceuticals and medical devices, and enhance the core competitiveness of China's pharmaceutical industry. Raise the level of development of intelligent supervision, promote “artificial intelligence+drug supervision”, explore the implementation of artificial intelligence-assisted reviews, and promote technological empowerment.